CIMATRON LIMITED | ||||||||||||||||
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION | ||||||||||||||||
(US Dollars in thousands, except for per share data) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended | ||||||||||
|
|
|
|
|
|
March, | ||||||||||
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
GAAP |
|
Adj. |
|
NON-GAAP |
|
GAAP |
|
Adj. |
|
NON-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
10,963 |
|
- |
|
10,963 |
|
10,158 |
|
- |
|
10,158 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of revenue (1) |
1,503 |
|
(147) |
|
1,356 |
|
1,326 |
|
(147) |
|
1,179 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
9,460 |
|
147 |
|
9,607 |
|
8,832 |
|
147 |
|
8,979 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses (2) |
1,915 |
|
(12) |
|
1,903 |
|
1,728 |
|
- |
|
1,728 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
6,474 |
|
|
|
6,337 |
|
6,326 |
|
|
|
6,273 | |||||
|
|
|
|
|
Non-cash amortization of acquired intangible assets |
|
|
- |
|
|
|
|
|
(53) |
|
|
|
|
|
|
|
Stock-based compensation |
|
|
(137) |
|
|
|
|
|
- |
|
|
Operating income |
1,071 |
|
296 |
|
1,367 |
|
778 |
|
200 |
|
978 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial income (expenses), net |
(39) |
|
- |
|
(39) |
|
16 |
|
- |
|
16 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxes on income (3) |
(350) |
|
(83) |
|
(433) |
|
(192) |
|
(91) |
|
(283) | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
(21) |
|
- |
|
(21) |
|
2 |
|
- |
|
2 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
661 |
|
213 |
|
874 |
|
604 |
|
109 |
|
713 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net income attributable to the noncontrolling interest |
(10) |
|
- |
|
(10) |
|
- |
|
- |
|
- | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to Cimatron's shareholders |
$ 651 |
|
$ 213 |
|
$ 864 |
|
$ 604 |
|
$ 109 |
|
$ 713 | |||||
Net income per share - basic and diluted |
$ 0.06 |
|
|
|
$ 0.08 |
|
$ 0.06 |
|
|
|
$ 0.08 | |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding |
|
|
|
|
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS (in thousands) |
10,731 |
|
|
|
10,731 |
|
9,348 |
|
|
|
9,348 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS (in thousands) |
10,731 |
|
|
|
10,731 |
|
9,358 |
|
|
|
9,358 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Non-GAAP adjustment to exclude non-cash amortization of acquired intangible assets |
|
|
|
| ||||||||||||
(2) Non-GAAP adjustment to exclude stock-based compensation |
|
|
|
|
|
| ||||||||||
(3) Non-GAAP adjustment to exclude the effect of deferred taxes and other non-current tax provisions. |
|
|
Cimatron Reports $11 Million Revenues in Q1/14, Marking Record First Quarter Revenues, Operating Profit and Cash Flow
| | More MCAD News |
|
RELATED NEWS